Thanks for posting this...it is "news you can use" for any big-pharma who is looking to market the added value offered by a new drug like Brilacidin. A pharmaceutical company can create a viable story for cost-savings...in addition to the increased effectiveness it offers. Brilacidin can become a "no-brainer" for educated prescribers & health plans. I'm sure potential suitors for this product look at data like this very closely when determining purchase price.